| Filed On | Filing |
|---|---|
| 10 Nov 2026 | 144 |
| 05 Nov 2026 |
Form 4: Roberts Eiry, Chief Medical Officer
Granted 8,314 Stock Option · Granted 1,506 Restricted Stock Unit |
| 03 Nov 2026 |
Form 4: Morrow George J, Director
Received 300 shares by exercise or conversion ($16.1K) · Sold 300 shares ($44.7K) · Received 7,500 shares by exercise or conversion ($402K) · 3 more |
| 03 Nov 2026 |
Form 4: Gano Kyle, Director
Received 614 shares by exercise or conversion · Gave up 332 shares to cover exercise price or tax ($48.5K) |
| 02 Nov 2026 | 144 |
| 02 Nov 2026 | 10-Q |
| 02 Nov 2026 |
8-K: Results of Operations and Financial Condition
Total Third-Quarter 2026 Revenue Grew 41% Year-Over-Year to $1.1 Billion |
| 30 Oct 2026 | 144 |
| 30 Oct 2026 | SCHEDULE 13G |
| 15 Oct 2026 | SCHEDULE 13G/A |
| 07 Oct 2026 |
Form 3: Roberts Eiry, Chief Medical Officer
Holds 51,331 shares of Common Stock |
| 28 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 28, 2026, the Board of Directors (the “Board”) of Neurocrine Biosciences, Inc. (the “Company”) appointed Eiry W. Roberts, M.D., to succeed Sanjay Keswani, M.D., as the Company’s Chief Medical Officer, effective September 28,... |
| 15 Sep 2026 |
Form 4: Onyia Jude, Chief Scientific Officer
Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K) |
| 15 Sep 2026 |
Form 4: Lippoldt Darin, Chief Legal Officer
Received 4,483 shares as a grant or award · Gave up 2,419 shares to cover exercise price or tax ($378K) |
| 15 Sep 2026 |
Form 4: Keswani Sanjay Chandru, Chief Medical Officer
Received 3,914 shares as a grant or award · Gave up 2,112 shares to cover exercise price or tax ($330K) |
| 15 Sep 2026 |
Form 4: Gorman Kevin Charles, Director
Received 14,343 shares as a grant or award · Gave up 7,839 shares to cover exercise price or tax ($1.22M) |
| 15 Sep 2026 |
Form 4: Gano Kyle, Director
Received 8,117 shares as a grant or award · Gave up 4,380 shares to cover exercise price or tax ($684K) |
| 15 Sep 2026 |
Form 4: Delaet Ingrid, Chief Regulatory Officer
Received 4,483 shares as a grant or award · Gave up 2,419 shares to cover exercise price or tax ($378K) |
| 15 Sep 2026 |
Form 4: Cooke Julie, Chief Human Resources Officer
Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K) |
| 15 Sep 2026 |
Form 4: Boyer David W., Chief Corp. Affairs Officer
Received 3,587 shares as a grant or award · Gave up 1,936 shares to cover exercise price or tax ($302K) · Sold 826 shares ($130K) |
Loading...